Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scotto

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology Reports|July 12, 2023
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case reportL Zumstein, V Tuninetti, M Vaira, et al.
Epidemiology and Infection|May 16, 2013
Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy)G Scotto, D Martinelli, M Centra, et al.
Archivio Monaldi Per Le Malattie Del Torace|September 1, 1987
[Invasive diagnosis and therapeutic program for solitary nodules of the lung]F Giampaglia, G Ferrante, C Cecere, et al.
European Journal of Epidemiology|July 8, 1999
Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological reportG Scotto, F Avcella, M Panunzio, et al.
Clinical Radiology|July 1, 2019
Accuracy of CT and MRI to assess resection margins in primary malignant bone tumours having histology as the reference standardL Cannavò, D Albano, C Messina, et al.
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Journal of Hepatology|October 11, 2001
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trialG Barbaro, F Zechini, A M Pellicelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2011
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-αC Scagnolari, S Trombetti, A Soldà, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in ItalyT Santantonio, E Medda, C Ferrari, et al.
The American Journal of Medicine|August 25, 1999
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trialG Barbaro, G Di Lorenzo, G Belloni, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology Reports|July 12, 2023
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case reportL Zumstein, V Tuninetti, M Vaira, et al.
Epidemiology and Infection|May 16, 2013
Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy)G Scotto, D Martinelli, M Centra, et al.
Archivio Monaldi Per Le Malattie Del Torace|September 1, 1987
[Invasive diagnosis and therapeutic program for solitary nodules of the lung]F Giampaglia, G Ferrante, C Cecere, et al.
European Journal of Epidemiology|July 8, 1999
Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological reportG Scotto, F Avcella, M Panunzio, et al.
Clinical Radiology|July 1, 2019
Accuracy of CT and MRI to assess resection margins in primary malignant bone tumours having histology as the reference standardL Cannavò, D Albano, C Messina, et al.
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Journal of Hepatology|October 11, 2001
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trialG Barbaro, F Zechini, A M Pellicelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2011
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-αC Scagnolari, S Trombetti, A Soldà, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in ItalyT Santantonio, E Medda, C Ferrari, et al.
The American Journal of Medicine|August 25, 1999
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trialG Barbaro, G Di Lorenzo, G Belloni, et al.
Pageof 8